MyDoc is preparing the ground for its enterprise healthcare platform to launch in Asian markets like Sri Lanka or Hong Kong.

MyDoc, a Singapore-based medtech spinout from Nanyang Technological University (NTU),  raised $5.2m in series A capital led by IT services provider UST Global today.

Venture capital firm Wavemaker Partners also contributed funding.

Founded in 2014, MyDoc’s online platform aims to compile medical information for insurers, doctors and patients. The spinout was founded by Vas Metupalle, a graduate of NTU’s Nanyang Business School, and Snehal Patel, a clinical fellow from the Harvard Medical School.

The latest edition, MyDoc@work, will launch by the end of 2017 and will target corporate health clients. Features include a policy breakdown, online prescriptions and video calls with practitioners.

Insurance conglomerates AIA Group and Axa use MyDoc within Singapore, as does the state-owned Health Promotion Board. MyDoc hopes to reach more Asian markets following trials in Sri Lanka and Hong Kong, the latter of which was regarded as particularly successful.

Wavemaker provided MyDoc with an undisclosed amount of seed funding in March 2016, according to deals database PitchBook, after an unspecified amount was received from August Capital Partners and Spring Seeds Capital, the VC arm of government initiative Spring Singapore, in 2014.

Snehal Patel said: “We are solving the pain point some corporates have with increasing healthcare costs.”